Evidence map›Paper›PMID 41501698›Full record

ArticleBMC nephrology2026

Health-related quality of life in nondialysis CKD patients: a comprehensive description of five-year trajectories among the CKD-REIN cohort.

Moustapha Faye, Lisa Le Gall, Aghilès Hamroun, Lucile Montalescot, Karen Leffondre, Natalia Alencar de Pinho, Bénédicte Stengel, Adama Faye, Luc Frimat, Abdou Omorou and 1 more

Abstract read
In one paragraph

Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Moustapha FayeCHRU-Nancy, INSERM, Université de Lorraine, CIC, Épidémiologie Clinique, INSPIIRE, Nancy, F-54000, France. Moustapha49.faye@ucad.edu.sn.ORCID 0000-0001-5321-9741
Lisa Le GallUniversity Bordeaux, INSERM, BPH, U1219, CIC 1401, Bordeaux, F-33000, France.
Aghilès HamrounPublic Health - Epidemiology, Nephrology Department, Lille University Hospital Center, Lille University, Lille, France.
Lucile MontalescotLaboratoire de Psychopathologie et Processus de Santé, Université Paris-Cité, Boulogne-Billancourt, France.
Karen LeffondreUniversity Bordeaux, INSERM, BPH, U1219, CIC 1401, Bordeaux, F-33000, France.
Natalia Alencar de PinhoCentre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm, Clinical Epidemiology team, Villejuif, 94800, France.
Bénédicte StengelCentre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm, Clinical Epidemiology team, Villejuif, 94800, France.
Adama FayeInstitut Santé et Développement (ISED), Université Cheikh Anta Diop, Dakar, Sénégal.
Luc FrimatCHRU-Nancy, INSERM, Université de Lorraine, CIC, Épidémiologie Clinique, INSPIIRE, Nancy, F-54000, France.
Abdou OmorouCHRU-Nancy, INSERM, Université de Lorraine, CIC, Épidémiologie Clinique, INSPIIRE, Nancy, F-54000, France.
CKD–REIN study collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFew studies have analyzed the quality-of-life trajectories of CKD patients not receiving kidney replacement therapy, and the results are inconsistent. This study aimed to identify subgroups of long-term trajectories of the physical (PCS) and mental components summary (MCS) of the KDQOL-36 in patients with CKD stages 3-5 and to describe their associations with patient characteristics.

methodsWe used a joint latent class-mixed model to identify the PCS and MCS trajectories of 2716 patients with CKD stages 3-5 enrolled in the CKD-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Quality-of-life was assessed annually using the Kidney Disease Quality-of-life-36. All the participants had scores for at least one-time point.

resultsDuring a median follow-up of 5.56 (4.77-6.16) years, 664 participants started KRT, and 465 died before KRT. We identified three profiles of PCS: a "High and declining PCS trajectory" which included 5.89% of patients, characterized by a higher initial score and a decline of more than 10 points over three years; a "High and stable PCS trajectory" in 50.96%, characterized by a higher initial score that remained stable; and a "Low and stable PCS trajectory" in 43.15%, characterized by a lower initial score that remained stable. For MCS, we identified a single, stable mean trajectory over time. A decline in eGFR was faster in participants with a "High and declining PCS trajectory" (-4.30 mL/min per years). Patients in the high and stable trajectory had a more favorable clinical and biological profile at baseline. The evolution of the specific dimensions of CKD within each PCS trajectory followed a pattern similar to that of the PCS itself.

conclusionsThe study highlights substantial heterogeneity in PCS evolution in patients with CKD, which contrasts with the stability of that for MCS.

Indexed as

Quality of LifeRenal Insufficiency, ChronicAgedCohort StudiesDisease ProgressionFemaleFollow-Up StudiesHumansMaleMiddle AgedChronic kidney diseaseClinical epidemiologyCohort studiesMental component summaryPhysical component summary

Identifiers

PMID41501698
PMCPMC12869980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.